Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/06/2014US20140065243 Methods and compositions for treating cancer
03/06/2014US20140065241 Uses of (-)-perhexiline
03/06/2014US20140065237 Biologically active food additive for the prophylaxis of erectile dysfunction in men
03/06/2014US20140065233 Injectable microspheres for dermal augmentation and tissue bulking
03/06/2014US20140065231 Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
03/06/2014US20140065230 Multiparticulate l-menthol formulations and related methods
03/06/2014US20140065226 Thermo-responsive hydrogel compositions
03/06/2014US20140065225 Modified release compositions comprising tacrolimus
03/06/2014US20140065224 Crystalline n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
03/06/2014US20140065222 Novel preparation technique for higher-order structure that exhibits anticellular effect
03/06/2014US20140065217 Multilayer tablet
03/06/2014US20140065215 Controlled release pharmaceutical formulations of nitazoxanide
03/06/2014US20140065214 Delayed-release glucocorticoid treatment of rheumatoid disease
03/06/2014US20140065213 Sustained Release Paracetamol Formulations
03/06/2014US20140065212 Coated pharmaceutical composition containing regorafenib
03/06/2014US20140065211 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
03/06/2014US20140065208 Prostate carcinogenesis predictor
03/06/2014US20140065205 Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
03/06/2014US20140065203 Antihistamine- and corticosteroid-containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders
03/06/2014US20140065199 Reactive Oxidative Species Generating Materials and Methods of Use
03/06/2014US20140065198 Medical Implants and Methods for Regulating the Tissue Response to Vascular Closure Devices
03/06/2014US20140065191 Topical pharmaceutical composition comprising nanonized silver sulfadiazine
03/06/2014US20140065174 Pharmaceutical composition for enhanching immunity, and extract of poria
03/06/2014US20140065168 Anti-kit antibodies and uses thereof
03/06/2014US20140065162 Compositions and Methods for Treating Brain Tumors
03/06/2014US20140065154 Tlr3 binding agents
03/06/2014US20140065153 Methods for Treating Hair Loss Disorders
03/06/2014US20140065147 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
03/06/2014US20140065141 Csf-1r inhibitors for treatment of brain tumors
03/06/2014US20140065140 Cancer treatment using viruses and camptothecins
03/06/2014US20140065139 Induction of Tumor Hypoxia for Cancer Therapy
03/06/2014US20140065136 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
03/06/2014US20140065134 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxity (adcc)
03/06/2014US20140065133 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection
03/06/2014US20140065128 TREATMENT FOR IgE-MEDIATED DISEASE
03/06/2014US20140065125 Pharmaceutical compositoin for treating depression and method for preparation thereof
03/06/2014US20140065120 Delivery of compounds with rehydrated blood cells
03/06/2014US20140065107 Devices, systems, and methods for modulating uterine function
03/06/2014US20140065103 Compounds and methods for the treatment or prevention of flaviviridae viral infections
03/06/2014US20140065102 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014US20140065101 2'-Branched Nucleosides for Treatment of Viral Infections
03/06/2014US20140065099 Methods of Treating Mitochondrial Dysfunction
03/06/2014US20140065096 Cancer therapy by ex vivo activated autologous immune cells
03/06/2014US20140065095 Novel inhibitors
03/06/2014US20140065093 Compositions For Achieving A Therapeutic Effect In An Anatomical Structure
03/06/2014US20140065090 Reactive Oxidative Species Generating Materials and Methods of Use
03/06/2014US20140065089 Hydrating composition
03/06/2014US20140065082 Topical skin care formulations
03/06/2014US20140065061 Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
03/06/2014US20140060532 Aerosol Forming Device For Use In Inhalation Therapy
03/06/2014DE102012017516A1 New 1-aryloxy-3-pyrrol-1-yl-propan-2-one derivatives are cytosolic phospholipase A2 inhibitors, useful for prophylactic or therapeutic treatment of diseases caused by increased activity of phospholipase A2, preferably e.g. pain and fever
03/06/2014DE102012017001A1 In situ generation of dronabinol-containing aerosols for therapeutic application, by a thermal process in electric cigarette or a principally similar device from precursors such as tetrahydrocannabinolic (A and/or B) or its salts
03/06/2014CA2877525A1 Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
03/06/2014CA2877502A1 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
03/06/2014CA2854927A1 The controlled release method for a pharmaceutical composition composed of chelating complex micelles
03/06/2014CA2836228A1 Pharmaceutical semi-solid composition of isotretinoin
03/05/2014EP2703491A1 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
03/05/2014EP2703487A1 Peptide for inducing regeneration of tissue and use thereof
03/05/2014EP2703407A1 Method for manufacturing phosphonocrotonic acid derivative
03/05/2014EP2703406A1 Novel cephem compound having catechol or pseudo-catechol structure
03/05/2014EP2703404A1 Buprenorphine analogs
03/05/2014EP2703402A1 Pharmacologically active alicyclic n,n'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon
03/05/2014EP2703401A1 Pyridine derivative and bace-1 inhibitor containing same
03/05/2014EP2703400A1 Phenyl pyrrole derivative crystal
03/05/2014EP2703399A1 Oxazine derivative and bace 1 inhibitor containing same
03/05/2014EP2703398A1 1,4-dihydropyridine -3,5-dicarboxylate derivatives, preparation methods and uses thereof
03/05/2014EP2703396A1 Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof
03/05/2014EP2703394A1 Novel 3-hydroxyisothiazole 1-oxide derivative
03/05/2014EP2703393A1 Cyclic amide derivative
03/05/2014EP2703392A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
03/05/2014EP2703387A1 Cyclohexyl-substituted piperazine compounds
03/05/2014EP2703004A1 Composition for improving male sexual function containing ginseng berry extract
03/05/2014EP2703000A1 Application of dwarf lilyturf tuber polysaccharide extract in preparation of dietary supplement, health food or medicine with the function of weight loss
03/05/2014EP2702999A1 Brain-targeting functional nucleic acid and use thereof
03/05/2014EP2702998A1 Therapeutic and diagnostic miRNA regulator in kidney disease
03/05/2014EP2702997A1 Method and composition for enhancing target cells uptake of therapeutic agents
03/05/2014EP2702996A1 Anemia-ameliorating composition
03/05/2014EP2702995A1 Rapidly dissolving oral tablet
03/05/2014EP2702994A2 Methods of administering pirfenidone therapy
03/05/2014EP2702993A1 Macrocyclic lactone compounds and methods for their use
03/05/2014EP2702992A1 Use of melatonin for treating and/or preventing mucositis
03/05/2014EP2702991A1 A composition of entacopone
03/05/2014EP2702990A1 Antiarrhythmic drug, atrial fibrillation inhibitor, model of sustained atrial fibrillation and method for producing same, and method for screening atrial fibrillation inhibitor
03/05/2014EP2702989A1 Stable pharmaceutical composition
03/05/2014EP2702988A2 Novel compositions and methods for treating hyperproliferative diseases
03/05/2014EP2702987A1 Phosphodiesterase type III (PDE III) inhibitors or Ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
03/05/2014EP2702986A1 Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
03/05/2014EP2702985A1 Equol Level Regulator
03/05/2014EP2702984A1 Drug-containing patch for treating local symptoms
03/05/2014EP2702983A1 Process for the preparation of a bispyridiniumalkane-containing semisolid preparation
03/05/2014EP2702878A1 Powdered starting material, bottle cap, and container comprising said bottle cap
03/05/2014EP2702172A1 Method for determining clinically relevant hypoxia in cancer
03/05/2014EP2702063A1 Bicyclic pyridazine compounds as pim inhibitors
03/05/2014EP2702062A1 Salt of an inhibitor of phosphodiesterase 10 enzyme
03/05/2014EP2702061A1 Pyrrolotriazinone derivatives as pi3k inhibitors
03/05/2014EP2702060A1 Acid addition salts of risperidone and pharmaceutical compositions thereof
03/05/2014EP2702059A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
03/05/2014EP2702058A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702055A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 7860